Abstract
Epstein–Barr virus (EBV) is the major triggering factor for hemophagocytic syndrome or hemophagocytic lymphohistiocytosis (HLH). In patients with EBV-HLH, the EBV-infected T cells or natural killer cells are mostly mono- or oligoclonally proliferating, whereby hypercytokinemia plays a major role and causes hemophagocytosis, cellular damage, and dysfunction of various organs. This report describes the detection and treatment of EBV-associated HLH in the case of a 17-year-old male. Serum samples and skin swabs were tested for the presence of viral DNA using real-time PCR techniques. To confirm the molecular biological tests, electron microscopy was also performed. EBV DNA was detected with real-time PCR in both blood samples and skin swabs. The level of viral DNA constantly decreased during the applied therapy. The presence of the virus in the skin was confirmed by the appearance of herpes virus-like particles detected by electron microscopy in fluid taken from skin ulcerations. The results show that in terms of treatment, special therapeutic measures are required to control the cytokine storm generated by EBV and to suppress proliferating EBV genome-containing cells because the clinical course is often fulminate and results in a poor outcome. Therefore the potential of chemotherapy with a combination of steroids, etoposide, and cyclosporine to control HLH was assessed in the adolescent, who met the stringent diagnostic criteria for this reactive disorder of the mononuclear phagocyte system.
Similar content being viewed by others
References
Chuang HC, Lay JD, Hsieh WC et al (2007) Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein–Barr virus associated T-cell lymphoma: nuclear factor-kappaB pathway as a potential therapeutic target. Cancer Sci 98:1281–1287
Fisman DN (2000) Hemophagocytic syndromes and infection. Emerg Infect Dis 6:601–608
Henter JI, Tondini C, Pritchard J (2004) Histiocyte disorders. Crit Rev Oncol Hematol 50:157–174
Imashuku S (2002) Clinical features and treatment strategies of Epstein–Barr virus associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44:259–272
Imashuku S, Kuriyama K, Teramura T et al (2001) Requirement for etoposide in the treatment of Epstein–Barr virus associated hemophagocytic lymphohistiocytosis. J Clin Oncol 19:2665–2673
Imashuku S, Teramura T, Tauchi H et al (2004) Longitudinal follow-up of patients with Epstein–Barr virus associated hemophagocytic lymphohistiocytosis. Haematologica 89:183–188
Iwatsuki K, Xu Z, Ohtsuka M et al (2000) Cutaneous lymphoproliferative disorders associated with Epstein–Barr virus infection: a clinical overview. J Dermatol Sci 22:181–195
Janka GE (2007) Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr 166:95–109
Jenson HB (2000) Acute complications of Epstein–Barr virus infectious mononucleosis. Curr Opin Pediatr 12:263–268
Kasahara Y, Yachie A (2002) Cell type specific infection of Epstein–Barr virus (EBV) in EBV associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol 44:283–294
Okano M (2000) Haematological associations of Epstein–Barr virus infection. Baillieres Best Pract Res Clin Haematol 13:199–214
Sullivan JL, Woda BA, Herrod HG et al (1985) Epstein–Barr virus associated hemophagocytic syndrome: virological and immunopathological studies. Blood 65:1097–1104
Tiab M, Mechinaud F, Harousseau JL (2000) Haemophagocytic syndrome associated with infections. Baillieres Best Pract Res Clin Haematol 13:163–178
Verbsky JW, Grossman WJ (2006) Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med 38:20–31
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Przybylski, M., Dzieciątkowski, T., Zduńczyk, D. et al. Microbiological Findings and Treatment of EBV-Associated Hemophagocytic Lymphohistiocytosis: A Case Report. Arch. Immunol. Ther. Exp. 58, 247–252 (2010). https://doi.org/10.1007/s00005-010-0071-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-010-0071-4